Vildegra Ozon: Compound Profile
Vildegra Ozon is a sildenafil citrate-based phosphodiesterase-5 (PDE5) inhibitor extensively studied for its vasodilatory properties in cardiovascular research. As part of the comprehensive selection available at Stroid UK Shop, this compound offers researchers a valuable tool for investigating nitric oxide signaling pathways and smooth muscle relaxation mechanisms. The formulation represents a standardised research-grade preparation suitable for controlled laboratory environments where precise pharmacological investigations are conducted.
Laboratory Research Applications
Researchers examining vascular biology frequently investigate Vildegra Ozon to study endothelial function and cyclic GMP pathways. The compound’s mechanism of action involves selective inhibition of PDE5, leading to increased levels of cyclic guanosine monophosphate in vascular smooth muscle cells. This makes it particularly valuable for studies examining pulmonary arterial pressure, coronary blood flow dynamics, and endothelial-dependent vasodilation responses. Scientists working within the broader field of erectile dysfunction research compounds often utilise this preparation to evaluate therapeutic pathways. Unlike the comprehensive range of SARMs or specialised peptides available for research, sildenafil-based compounds specifically target phosphodiesterase enzyme systems, making them essential for cardiovascular and urological research protocols.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Sildenafil Citrate |
| Mechanism | PDE5 Inhibitor |
| Storage | Room temperature, dry environment |
| Purity | Verify with supplier |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S (citrate salt) |
| CAS Number | Verify with supplier |
| Research Grade | Laboratory standard |
Compliance and Research Use
Vildegra Ozon is intended strictly for in-vitro laboratory research and educational purposes only. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure appropriate institutional oversight, proper laboratory safety protocols, and compliance with all applicable regulations when conducting studies with this compound. All investigations should be performed by qualified personnel within licensed research facilities with appropriate safety equipment and waste disposal procedures.
